ReviewFrontiers in veterinary science2026
Reservoirs of Getah virus: an update review.
Review in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Getah virus (GETV) is a mosquito-borne RNA virus whose cross-species transmission poses a potential threat to both animal and public health. Studies have revealed that the reservoir range of GETV is broad, ranging from primary vectors (e.g., mosquitoes) and key amplifying hosts (e.g., horses and pigs) to a variety of newly identified hosts such as foxes, cattle, red pandas, and squirrels. Notably, although no confirmed clinical cases in humans have been reported to date, serological evidence from healthy individuals and febrile patients in tropical and subtropical regions of Asia and Oceania suggests possible subclinical or past infections. Furthermore, the detection of GETV in wastewater treatment plants and its contamination of veterinary vaccines underscore the risks of environmental and iatrogenic transmission. These findings demonstrate the broad host diversity and multiple transmission routes of GETV, highlighting the need to monitor and mitigate its cross-species transmission risks. This review comprehensively summarizes the known reservoirs of GETV, with the aim of informing future research and control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.